App-Quantinova.ai

Association Vitamin D Status with Subclinical Atherosclerosis in Patients with Type 2 Diabetes Mellitus

Kyu-jin Kim - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Ergocalciferol

Mineralocorticoid Markers of Hypertension Are Associated with Immune Signaling Molecules

Andrea Vecchiola - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Relationship Between Circulating Betatrophin Levels and Insulin Resistance in Prediabetic Subjects

Mehmet Calan - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

betatrophin

Incident Prediabetes in Relation to Baseline Adiponectin and hsCRP Levels in a Biracial Cohort Study of Normoglycemic Offspring of Diabetic Parents

Yunna Jiang - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

N/A

Beneficial Effects of Ramadan Fasting in Saudi Arabia Might be Offset By Changes in Secretion Pattern of Adipokines and Increased Insulin Resistance

Suhad Bahijri - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Cardiometabolic syndrome

N/A

Association of Serum High-Sensitivity C - Reactive Protein to Metabolic Control and Chronic Vascular Complications in Patients with Type 2 Diabetes

Somlak Chuengsamarn - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Peripheral neuropathy

N/A

Circulating Receptor Activator of Nuclear Factor ?B Ligand and Osteoprotegerin in Prediabetes: Relationships to Cardiovascular Risk

Esra Tutal - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

N/A

African American Nondiabetic, Postmenopausal Women (AAW) Are More Resistant to Anti-Inflammatory Effect of Aspirin Therapy Than White Women (WAW)

Nora Alghothani - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

Aspirin

Uric Acid-Induced Low Grade Inflammation Is Mediated By Parathyroid Hormone: 25-Hydroxyvitamin D Ratio in Obese Adolescents

Ramin Alemzadeh - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vitamin D deficiency

Parathyroid hormone

Improved Oral Glucose Tolerance in Prediabetics and Type 2 Diabetics (T2D) in a Pilot Clinical Trial Testing a Novel Gastrointestinal (GI) Microbiome Modulator

Mark Louis Heiman - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

ghrelin

The Effect of Soy Phytoestrogens on Cardiovascular Risk Markers in Men with Type 2 Diabetes and Subclinical Hypogonadism - a Randomised Double Blind Parallel Study

Thozhukat Sathyapalan - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Resistin and Obesity

Elena Parreno Caparros - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

Interleukin

Resistance Training Improves Metainflammation and Body Composition in Obese Adolescents

Rachana Dahiya - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Interleukin

Carotid Wall Thickness in Adolescents with Classical Congenital Adrenal Hyperplasia Is Not Different from Matched Controls

Mimi S Kim - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congenital adrenal hyperplasia

Hydroxyprogesterone caproate

Endothelial Dysfunction, Insulin Resistance and Inflammation Are Present in Young Patients with Congenital Hypogonadism and Do Not Improve after the Testosterone Replacement Therapy

Alper Sonmez - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vasodilation dysfunction

N/A

Plasma Biomarkers of Iron Regulation, Overload, and Inflammation in Sickle Cell Disease

Abhishek Mangaonkar - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Systemic inflammation

ILS-969

Increased Von Willebrand Factor and High Circulating Placental Growth Factor Correlate with Inflammation and Iron Overload in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia

Ersi Voskaridou - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Vasodilation dysfunction

Hydroxycarbamide

Assessment of Serum Bioactive Hepcidin-25, Soluble Transferrin Receptor and Their Ratio in Predialysis Patients: Correlation with the Response to Intravenous Ferric Carboxymaltose Administration

Athina Drakou - American Society of Hematology (ASH) , 2015

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Polycystic kidney disease

Ferric carboxymaltose

Accelerated arterial stiffening occurs in obese and diabetic youth

Elaine M. Urbina - American Society of Hypertension (ASHy) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Type 2 diabetes mellitus

N/A

Predictors of changes in cardiac structure and diastolic function at dipper and non-dipper treated hypertensive patients

Olena Matova - American Society of Hypertension (ASHy) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Diastolic dysfunction

N/A

Filters

1408 Abstracts